Longitudinal PET-MRI reveals β-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion
Author(s) -
Florian Maier,
Hans F. Wehrl,
Andreas M. Schmid,
Julia G. Mannheim,
Stefan Wiehr,
Chommanad Lerdkrai,
Carsten Calaminus,
Anke Stahlschmidt,
Lan Ye,
Michael Burnet,
Detlef Stiller,
Osama Sabri,
Gerald Reischl,
M Staufenbiel,
Olga Garaschuk,
Mathias Jucker,
Bernd J. Pichler
Publication year - 2014
Publication title -
nature medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.536
H-Index - 547
eISSN - 1546-170X
pISSN - 1078-8956
DOI - 10.1038/nm.3734
Subject(s) - cerebral amyloid angiopathy , amyloidosis , pittsburgh compound b , amyloid (mycology) , cerebral blood flow , pathology , positron emission tomography , magnetic resonance imaging , perfusion , alzheimer's disease , genetically modified mouse , in vivo , medicine , neuroscience , disease , biology , transgene , dementia , radiology , biochemistry , microbiology and biotechnology , gene
The dynamics of β-amyloid deposition and related second-order physiological effects, such as regional cerebral blood flow (rCBF), are key factors for a deeper understanding of Alzheimer's disease (AD). We present longitudinal in vivo data on the dynamics of β-amyloid deposition and the decline of rCBF in two different amyloid precursor protein (APP) transgenic mouse models of AD. Using a multiparametric positron emission tomography and magnetic resonance imaging approach, we demonstrate that in the presence of cerebral β-amyloid angiopathy (CAA), β-amyloid deposition is accompanied by a decline of rCBF. Loss of perfusion correlates with the growth of β-amyloid plaque burden but is not related to the number of CAA-induced microhemorrhages. However, in a mouse model of parenchymal β-amyloidosis and negligible CAA, rCBF is unchanged. Because synaptically driven spontaneous network activity is similar in both transgenic mouse strains, we conclude that the disease-related decline of rCBF is caused by CAA.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom